A detailed history of Amalgamated Bank transactions in Celcuity Inc. stock. As of the latest transaction made, Amalgamated Bank holds 581 shares of CELC stock, worth $8,075. This represents 0.0% of its overall portfolio holdings.

Number of Shares
581
Previous 581 -0.0%
Holding current value
$8,075
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$13.74 - $21.6 $12,668 - $19,915
-922 Reduced 61.34%
581 $13,000
Q4 2023

Feb 06, 2024

SELL
$8.7 - $15.02 $1,505 - $2,598
-173 Reduced 10.32%
1,503 $22,000
Q2 2023

Aug 11, 2023

BUY
$9.39 - $12.18 $15,737 - $20,413
1,676 New
1,676 $18,000
Q2 2022

Aug 15, 2022

SELL
$5.35 - $10.11 $8,420 - $15,913
-1,574 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$7.93 - $13.33 $12,481 - $20,981
1,574 New
1,574 $15,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $208M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.